Table 4.
ART outcomes women divided according to POSEIDON stratification.
| Variable | Group 1 | Group 2 | Group 3 | Group 4 | p-value |
|---|---|---|---|---|---|
| Total FSH doses (IU/L) | 2,182 ± 998 | 2,882 ± 1,127 | 3,282 ± 1,380 | 3,624 ± 1,329 | <0.001 |
| Total LH dose (IU/L) | 50 ± 236 | 137 ± 406 | 219 ± 545 | 351 ± 654 | <0.001 |
| Oocytes retrieved | 6.68 ± 1.91 | 6.38 ± 2.09 | 5.69 ± 2.22 | 5.13 ± 2.21 | <0.001 |
| FSH dose/oocytes ratio | 380 ± 280 | 561 ± 520 | 779 ± 709 | 970 ± 874 | <0.001 |
| MII oocytes | 5.11 ± 2.05 | 4.87 ± 2.02 | 4.21 ± 2.03 | 3.83 ± 1.97 | <0.001 |
| MII oocytes/oocytes retrieved | 0.76 ± 0.22 | 0.76 ± 0.21 | 0.74 ± 0.23 | 0.75 ± 0.25 | 0.187 |
| Injected oocytes | 5.01 ± 2.01 | 4.74 ± 2.01 | 4.09 ± 2.02 | 3.74 ± 1.96 | <0.001 |
| Frozen oocytes | 0.01 ± 0.17 | 0.07 ± 0.62 | 0.03 ± 0.39 | 0.03 ± 0.39 | 0.097 |
| Fertilized oocytes | 3.64 ± 1.92 | 3.46 ± 1.89 | 2.95 ± 1.89 | 2.65 ± 1.73 | <0.001 |
| Cumulative embryos | 2.31 ± 1.14 | 2.36 ± 1.20 | 2.00 ± 1.15 | 2.05 ± 1.12 | <0.001 |
| Transferred embryos | 1.69 ± 0.63 | 1.96 ± 0.99 | 1.59 ± 0.71 | 1.88 ± 0.99 | <0.001 |
| Frozen embryos | 0.63 ± 1.00 | 0.40 ± 0.90 | 0.42 ± 0.85 | 0.17 ± 0.54 | <0.001 |
| Implantation rate | 20.64 ± 35.17 | 13.03 ± 26.19 | 19.70 ± 26.19 | 10.57 ± 24.48 | <0.001 |
| Biochemical pregnancies n (%) | 91 (30.1%) | 199 (23.9%) | 144 (29.1%) | 500 (19.2%) | <0.001 |
| Deliveries n (%) | 82 (27.1%) | 136 (16.3%) | 119 (24.0%) | 334 (12.8%) | <0.001 |
| Miscarriage n (%)* | 8 (2.6%) | 59 (7.1%) | 23 (4.6%) | 158 (6.1%) | <0.001 |
| Miscarriage n (%)** | 8 (8.8%) | 59 (29.6%) | 23 (16.0%) | 158 (31.6%) | |
| Ectopic pregnancies n (%)* | 1 (0.3%) | 4 (0.5%) | 2 (0.4%) | 9 (0.3%) | <0.001 |
| Ectopic pregnancies n (%)** | 1 (1.1%) | 4 (2.0%) | 2 (1.4%) | 9 (1.8%) |
Data are expressed as mean ± standard deviation or number (percentage).
% Considering the total number of cycles.
% Considering the number of clinical pregnancies.
Bold values, represent statistical significant p-values.